Acam Pharma Private Limited
About Acam Pharma Private Limited
Data last updated:
Acam Pharma Private Limited is a private limited company based in Meerut, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 20 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24110UP2018PTC103455. Its GSTIN is 09AAQCA8179D1Z6 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹40,000. It is led by directors Mrinal Sharma and Akshay Sharma.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 66 Lane No. 4 New Bhopal Vihar Near Ajay Hospital Garh Road, Meerut, Uttar Pradesh, India – 250004.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.81 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹25,817 (net margin 0.6%) and EBITDA of ₹2.13 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 32% over five years.
As per MCA filings, the company has open charges of ₹9.9 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 66 Lane No. 4 New Bhopal Vihar Near Ajay Hospital Garh Road, Meerut, Uttar Pradesh, India – 250004
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Acam Pharma Private Limited
The main business activity of Acam Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Acam Pharma Private Limited FY 2025 filings available
Acam Pharma Private Limited reported revenue of ₹41.81 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Acam Pharma Private Limited
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 32%. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Acam Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.13 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25,817 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Acam Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acam Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Acam Pharma Private Limited
Acam Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inno Ausbildung Private Limited | ₹41.85 Lakh (FY 2025) | •••• | •••• | 80.0% | •••• | Meenachil, Kerala, India |
| Epitome Retail Private Limited | ₹41.84 Lakh (FY 2025) | •••• | •••• | -89.0% | •••• | Chandigarh, India |
| Davi India Retail & Trade Private Limited | ₹41.84 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Gem & Company Private Limited | ₹41.84 Lakh (FY 2020) | •••• | •••• | 34.0% | •••• | Tamil Nadu, India |
| Anisha Fashions Private Limited | ₹41.82 Lakh (FY 2025) | •••• | •••• | -58.0% | •••• | Kolkata, West Bengal, India |
| Acam Pharma Private Limited this company | ₹41.81 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Meerut, Uttar Pradesh, India |
| Aegis Spread Private Limited | ₹41.81 Lakh (FY 2024) | •••• | •••• | -29.0% | •••• | Ahmedabad, Gujarat, India |
| Le Rouge Trendz Private Limited | ₹41.79 Lakh (FY 2025) | •••• | •••• | -63.0% | •••• | Thane, Maharashtra, India |
| Krushi Yantra Agrotech India Private Limited | ₹41.79 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Ahmedabad, Gujarat, India |
| Sugnani Enterprises (India) Private Limited | ₹41.79 Lakh (FY 2025) | •••• | •••• | 134.0% | •••• | Margao, Goa, India |
| Defassa Exim Private Limited | ₹41.79 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Acam Pharma by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Acam Pharma Private Limited
Acam Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mrinal Sharma | Director | 20 Apr 2018 | 8 Years 5 Months | Current |
| Akshay Sharma | Director | 20 Apr 2018 | 8 Years 5 Months | Current |
Ownership and Shareholding of Acam Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Acam Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2023 | Others | ₹9.9 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Acam Pharma Private Limited
Employment history and EPFO contributions of people linked to Acam Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Acam Pharma Private Limited
Acam Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Akshay Sharma was appointed as Director on 20 Apr 2018.
Credit Ratings, Litigation & Regulatory Alerts for Acam Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acam Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acam Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Acam Pharma Private Limited
Acam Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCA8179D1Z6 | Uttar Pradesh | Active | 01 Jan 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acam Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acam Pharma Private Limited
Acam Pharma is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 20 April 2018 (8+ years old) and is registered under CIN U24110UP2018PTC103455.
Acam Pharma reported revenue of ₹41.81 Lakh for FY 2025 (down 3% YoY).
Acam Pharma has 2 current directors:
- Mrinal Sharma - Director
- Akshay Sharma - Director
Acam Pharma reported a net profit of ₹25,817 (net margin 0.6%) and EBITDA of ₹2.13 Lakh (EBITDA margin 5.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Acam Pharma is 4% over three years and 32% over five years. In the latest year (FY 2025) revenue fell 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Acam Pharma is 09AAQCA8179D1Z6, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Acam Pharma is U24110UP2018PTC103455. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acam Pharma was incorporated on 20 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Acam Pharma by revenue are Inno Ausbildung Private Limited, Epitome Retail Private Limited, Davi India Retail & Trade Private Limited, Gem & Company Private Limited, Anisha Fashions Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Akshay Sharma was appointed as Director on 20 Apr 2018. Mrinal Sharma was appointed as Director on 20 Apr 2018.
Yes, Acam Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).